These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 26590052

  • 1. Effects of cyclophosphamide on the prognosis of Japanese patients with renal vasculitis associated with anti-neutrophil cytoplasmic antibody-positive microscopic polyangiitis.
    Iwabuchi M, Nakaya I, Tsuchiya Y, Shibagaki Y, Yamaguchi T, Fukuhara S, Oe Y, Sakuma T, Sato T, Taguma Y, Soma J.
    Clin Exp Nephrol; 2016 Oct; 20(5):712-719. PubMed ID: 26590052
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome and efficacy of cyclophosphamide therapy in Japanese patients with ANCA-associated microscopic polyangiitis: a retrospective study.
    Nakaya I, Yahata M, Takahashi S, Sasajima T, Sakuma T, Shibagaki Y, Soma J.
    Intern Med; 2013 Oct; 52(22):2503-9. PubMed ID: 24240788
    [Abstract] [Full Text] [Related]

  • 3. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, Fujimoto S, Muso E, Murakawa Y, Arimura Y, Makino H, Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.
    Arthritis Res Ther; 2015 Nov 02; 17():305. PubMed ID: 26525413
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
    PLoS One; 2017 Nov 02; 12(10):e0185880. PubMed ID: 29016646
    [Abstract] [Full Text] [Related]

  • 5. [Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment].
    Paolini MV, Ruffino JP, Fernández Romero DS.
    Medicina (B Aires); 2013 Nov 02; 73(2):119-26. PubMed ID: 23570759
    [Abstract] [Full Text] [Related]

  • 6. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR, European Vasculitis Society (EUVAS).
    Ann Rheum Dis; 2015 Jun 02; 74(6):1178-82. PubMed ID: 25739829
    [Abstract] [Full Text] [Related]

  • 7. Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A propensity score-matched analysis of two nationwide prospective cohort studies.
    Watanabe H, Sada KE, Matsumoto Y, Harigai M, Amano K, Fujimoto S, Dobashi H, Yuzawa Y, Yamagata K, Muso E, Arimura Y, Makino H.
    Mod Rheumatol; 2021 Jan 02; 31(1):205-213. PubMed ID: 31859544
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.
    Silva F, Specks U, Kalra S, Hogan MC, Leung N, Sethi S, Fervenza FC.
    Clin J Am Soc Nephrol; 2010 Mar 02; 5(3):445-53. PubMed ID: 20093349
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of mycophenolate mofetil treatment for patients with microscopic polyangiitis: an observational study in Chinese patients.
    Chen Y, Gao E, Yang L, Liu X, Li K, Liu Z, Zeng C, Zhang H, Liu Z, Hu W.
    Rheumatol Int; 2016 Jul 02; 36(7):967-74. PubMed ID: 27169414
    [Abstract] [Full Text] [Related]

  • 10. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM, Mejía-Vilet JM, Morales-Buenrostro LE, Loyola-Rodríguez G, Uribe-Uribe NO, Correa-Rotter R.
    Clin Rheumatol; 2016 Jul 02; 35(7):1805-16. PubMed ID: 26852317
    [Abstract] [Full Text] [Related]

  • 11. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S, Hruskova Z, Segelmark M, Morgan MD, Hogan J, Lee SK, Dale J, Harper L, Tesar V, Jayne DR, Geetha D.
    Am J Nephrol; 2015 Jul 02; 41(4-5):296-301. PubMed ID: 26044574
    [Abstract] [Full Text] [Related]

  • 12. Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis.
    Kitagawa K, Furuichi K, Sagara A, Shinozaki Y, Kitajima S, Toyama T, Hara A, Iwata Y, Sakai N, Shimizu M, Kaneko S, Wada T, Kanazawa Study Group for Renal Diseases and Hypertension.
    Clin Exp Nephrol; 2016 Oct 02; 20(5):703-711. PubMed ID: 26590051
    [Abstract] [Full Text] [Related]

  • 13. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ.
    Am J Kidney Dis; 2015 Oct 02; 66(4):613-20. PubMed ID: 25975963
    [Abstract] [Full Text] [Related]

  • 14. Outcome and treatment of elderly patients with ANCA-associated vasculitis.
    Weiner M, Goh SM, Mohammad AJ, Hruskova Z, Tanna A, Bruchfeld A, Selga D, Chocova Z, Westman K, Eriksson P, Pusey CD, Tesar V, Salama AD, Segelmark M.
    Clin J Am Soc Nephrol; 2015 Jul 07; 10(7):1128-35. PubMed ID: 26100457
    [Abstract] [Full Text] [Related]

  • 15. Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan.
    Furuta S, Chaudhry AN, Hamano Y, Fujimoto S, Nagafuchi H, Makino H, Matsuo S, Ozaki S, Endo T, Muso E, Ito C, Kusano E, Yamagata M, Ikeda K, Kashiwakuma D, Iwamoto I, Westman K, Jayne D.
    J Rheumatol; 2014 Feb 07; 41(2):325-33. PubMed ID: 24429174
    [Abstract] [Full Text] [Related]

  • 16. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE, Sanders JSF, Puéchal X, Guillevin LP, Hiemstra TF, Flossmann O, Rasmussen N, Westman K, Jayne DR, Stegeman CA.
    Rheumatology (Oxford); 2017 Nov 01; 56(11):1894-1901. PubMed ID: 28977502
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.
    Nephrol Dial Transplant; 2008 Apr 01; 23(4):1307-12. PubMed ID: 18065810
    [Abstract] [Full Text] [Related]

  • 18. Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvement: Analysis of 89 cases.
    Caravaca-Fontán F, Yerovi E, Delgado-Yagu E M, Galeano C, Pampa-Saico S, Tenorio MT, Liaño F.
    Med Clin (Barc); 2017 Jan 06; 148(1):1-7. PubMed ID: 28196580
    [Abstract] [Full Text] [Related]

  • 19. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S.
    Allergol Int; 2007 Jun 06; 56(2):87-96. PubMed ID: 17460438
    [Abstract] [Full Text] [Related]

  • 20. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS, de Joode AA, DeSevaux RG, Broekroelofs J, Voskuyl AE, van Paassen P, Kallenberg CG, Tervaert JW, Stegeman CA.
    Nephrol Dial Transplant; 2016 Sep 06; 31(9):1453-9. PubMed ID: 27242368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.